INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹12 Cr | ₹6.14 Cr | ₹11 Cr | ₹-19 Cr | ₹-36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDOCO REMEDIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹12 Cr |
Mar2023 | ₹6.14 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹-19 Cr |
Mar2020 | ₹-36 Cr |
How is Deferred Tax Assets / Liabilities of INDOCO REMEDIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹12 Cr | 92.58 | |
Mar2023 | ₹6.14 Cr | -42.06 | |
Mar2022 | ₹11 Cr | Positive | |
Mar2021 | ₹-19 Cr | Negative | |
Mar2020 | ₹-36 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,984.1 Cr | -3.8% | -3.3% | -14% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -3.8% |
-3.3% |
-14% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses